BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,481,000 | +4.8% | 16,410 | +1.0% | 0.03% | +13.0% |
| Q2 2022 | $2,367,000 | +25.3% | 16,245 | +1.9% | 0.02% | +53.3% |
| Q1 2022 | $1,889,000 | -13.5% | 15,935 | +0.6% | 0.02% | -11.8% |
| Q4 2021 | $2,183,000 | -1.5% | 15,842 | -0.7% | 0.02% | -5.6% |
| Q3 2021 | $2,216,000 | +55.6% | 15,953 | +8.8% | 0.02% | +50.0% |
| Q2 2021 | $1,424,000 | +40.4% | 14,664 | -1.1% | 0.01% | +33.3% |
| Q1 2021 | $1,014,000 | -19.6% | 14,831 | +0.8% | 0.01% | -18.2% |
| Q4 2020 | $1,261,000 | +29.2% | 14,713 | -2.0% | 0.01% | +10.0% |
| Q3 2020 | $976,000 | +19.3% | 15,012 | +34.3% | 0.01% | -16.7% |
| Q2 2020 | $818,000 | +130.4% | 11,182 | +7.3% | 0.01% | +100.0% |
| Q1 2020 | $355,000 | – | 10,425 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |